Discovery Date: 1973 GHK-Cu is not approved for human consumption, medical use, or therapeutic application
In some embodiments, the otic formulation or composition comprises about 0.03% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
This technique is important
Studies in animals have demonstrated such movement across the intact blood-brain barrier, particularly in the younger as opposed to the more mature animal, and the occurrence of kernicterus in older children with apparently intact blood-brain barriers further supports this concept
Your muscles get a sustained supply, not one spike that fades
Larger, longer, higher-quality trials are needed to determine the effects of L-carnitine on athletic performance